Clinical Trials Logo

Clinical Trial Summary

This study will assess whether coffee consumption:

- increases immune responses

- decreases inflammatory status


Clinical Trial Description

Epidemiological studies suggest that coffee consumption is associated with protective effects against several types of chronic diseases. Recent data have shown that certain coffee components may possess anti-inflammatory and immune-enhancing properties. Low-grade inflammation and poor capacity of immune response is highly prevalent in elderly subjects.

The purpose of this study is to evaluate whether coffee consumption improves immune and inflammatory status in healthy elderly subjects. To sort out the role of antioxidants, we will test 2 different soluble coffee, i.e. fully torrefied coffee and partially torrefied coffee. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00860197
Study type Interventional
Source University of Chile
Contact
Status Completed
Phase N/A
Start date March 2009
Completion date February 2010

See also
  Status Clinical Trial Phase
Completed NCT02011672 - Effect of Milk Ingredients on Glucose Regulation and Inflammation N/A
Active, not recruiting NCT01390688 - Brain-derived Neurotrophic Factor and Cogntive Function N/A
Completed NCT02342496 - Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly N/A
Completed NCT01414647 - The Health Effect of Diet Rich in Nordic Berries N/A
Not yet recruiting NCT06355544 - Individual Factors Related to Chronic Low-grade Inflammation and Cardiometabolic Disease Risk